{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:36:01Z","timestamp":1777181761430,"version":"3.51.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241056, 82530002"],"award-info":[{"award-number":["82241056, 82530002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["824B2001"],"award-info":[{"award-number":["824B2001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170015, 82570008"],"award-info":[{"award-number":["82170015, 82570008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["CIFMS 2021-I2M-1-048, 2024-I2M-ZD-011"],"award-info":[{"award-number":["CIFMS 2021-I2M-1-048, 2024-I2M-ZD-011"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"name":"New Cornerstone Science Foundation and the Fundamental Research Funds for the Central Universities"},{"name":"Excellence & Innovation Initiative of China-Japan Friendship Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Respiratory viral infections, such as influenza and COVID-19, pose significant global health challenges. For patients with invasive pulmonary aspergillosis, a subsequent viral infection can lead to markedly worse clinical outcomes. Although amphotericin B (AmB) remains a cornerstone antifungal therapy, our investigation demonstrates that it paradoxically enhances the entry of influenza A virus and SARS-CoV-2. Mechanistically, AmB directly binds to and activates glucocerebrosidase, leading to ceramide accumulation and RAB7 upregulation in the late endosomes, thereby enhancing late endosomal maturation and fusion with viruses. In animal models, AmB treatment enhances viral infection in both influenza A virus\u2013infected mice and SARS-CoV-2\u2013challenged hamsters, resulting in accelerated weight loss, higher viral loads, and aggravated tissue damage. Consistently, in our propensity score-matched cohort of patients with culture-confirmed invasive pulmonary aspergillosis (2016\u20132025, n\u2009=\u20091,072), systemic use of AmB is associated with a significantly higher incidence of subsequent viral infection compared to other antifungals (21.55% vs. 7.76%, P\u2009=\u20090.003), which is further supported by multivariable analysis confirming AmB as an independent risk factor (adjusted OR\u2009=\u20093.45, 95% CI 2.20\u20135.41, P\u2009=\u20097.174 \u00d7 10\n                    <jats:sup>-8<\/jats:sup>\n                    ). In summary, our findings provide crucial clinical evidence to guide antifungal therapy and reveal glucocerebrosidase as a potential target for developing novel antiviral strategies.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-70095-x","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T05:16:26Z","timestamp":1773033386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amphotericin B promotes respiratory viral entry by enhancing late endosomal maturation and fusion via glucocerebrosidase-mediated ceramide remodeling"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8505-6653","authenticated-orcid":false,"given":"Di","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenting","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiankang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianxia","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yameng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5732-4848","authenticated-orcid":false,"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6045-2007","authenticated-orcid":false,"given":"Peigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8548-1362","authenticated-orcid":false,"given":"Zai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6991-0350","authenticated-orcid":false,"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"70095_CR1","unstructured":"World Health Organization. The burden of influenza. Available at: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/the-burden-of-influenza. (Accessed: 2025)."},{"key":"70095_CR2","unstructured":"World Health Organization. WHO COVID-19 dashboard. Available at: https:\/\/data.who.int\/dashboards\/covid19. (Accessed: 2025)."},{"key":"70095_CR3","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","volume":"6","author":"A Schauwvlieghe","year":"2018","unstructured":"Schauwvlieghe, A. et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir. Med. 6, 782\u2013792 (2018).","journal-title":"Lancet Respir. Med."},{"key":"70095_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","volume":"10","author":"JP Gangneux","year":"2022","unstructured":"Gangneux, J. P. et al. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study. Lancet Respir. Med. 10, 180\u2013190 (2022).","journal-title":"Lancet Respir. Med."},{"key":"70095_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes, J. et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin. Microbiol. Infect. 28, 580\u2013587 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"70095_CR6","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.3201\/eid2711.211174","volume":"27","author":"NAF Janssen","year":"2021","unstructured":"Janssen, N. A. F. et al. Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis(1). Emerg. Infect. Dis. 27, 2892\u20132898 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"70095_CR7","doi-asserted-by":"publisher","unstructured":"Feys, S. et al. A visual and comprehensive review on COVID-19-associated pulmonary Aspergillosis (CAPA). J. Fungi 7 https:\/\/doi.org\/10.3390\/jof7121067 (2021).","DOI":"10.3390\/jof7121067"},{"key":"70095_CR8","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.3201\/eid2709.210934","volume":"27","author":"A Patel","year":"2021","unstructured":"Patel, A. et al. Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India. Emerg. Infect. Dis. 27, 2349\u20132359 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"70095_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12941-025-00805-8","volume":"24","author":"M Xie","year":"2025","unstructured":"Xie, M. et al. SARS-CoV-2 coinfection in patients with invasive pulmonary aspergillosis: clinical characteristics and prognosis. Ann. Clin. Microbiol. Antimicrob. 24, 38 (2025).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"70095_CR10","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/S1473-3099(22)00124-4","volume":"22","author":"V Muthu","year":"2022","unstructured":"Muthu, V. et al. Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India. Lancet Infect. Dis. 22, e240\u2013e253 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"70095_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","volume":"12","author":"S Feys","year":"2024","unstructured":"Feys, S. et al. Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients. Lancet Respir. Med. 12, 728\u2013742 (2024).","journal-title":"Lancet Respir. Med."},{"key":"70095_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo2658","volume":"8","author":"Y Umegawa","year":"2022","unstructured":"Umegawa, Y. et al. Amphotericin B assembles into seven-molecule ion channels: An NMR and molecular dynamics study. Sci. Adv. 8, eabo2658 (2022).","journal-title":"Sci. Adv."},{"key":"70095_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1681\/ASN.V62154","volume":"6","author":"BP Sawaya","year":"1995","unstructured":"Sawaya, B. P., Briggs, J. P. & Schnermann, J. Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. J. Am. Soc. Nephrol. 6, 154\u2013164 (1995).","journal-title":"J. Am. Soc. Nephrol."},{"key":"70095_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep33150","volume":"6","author":"F Xu","year":"2016","unstructured":"Xu, F. et al. Amphotericin B inhibits enterovirus 71 replication by impeding viral entry. Sci. Rep. 6, 33150 (2016).","journal-title":"Sci. Rep."},{"key":"70095_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/atm.ATM_147_20","volume":"15","author":"FHO Al-Khikani","year":"2020","unstructured":"Al-Khikani, F. H. O. Amphotericin B as antiviral drug: possible efficacy against COVID-19. Ann. Thorac. Med. 15, 118\u2013124 (2020).","journal-title":"Ann. Thorac. Med."},{"key":"70095_CR16","doi-asserted-by":"publisher","unstructured":"Xing, Y. et al. Multifaceted functions of host cell caveolae\/caveolin-1 in virus infections. Viruses 12 https:\/\/doi.org\/10.3390\/v12050487 (2020).","DOI":"10.3390\/v12050487"},{"key":"70095_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1128\/jvi.69.1.570-574.1995","volume":"69","author":"O Pleskoff","year":"1995","unstructured":"Pleskoff, O., Seman, M. & Alizon, M. Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion. J. Virol. 69, 570\u2013574 (1995).","journal-title":"J. Virol."},{"key":"70095_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.celrep.2013.10.033","volume":"5","author":"TY Lin","year":"2013","unstructured":"Lin, T. Y. et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 5, 895\u2013908 (2013).","journal-title":"Cell Rep."},{"key":"70095_CR19","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1080\/22221751.2020.1787797","volume":"9","author":"M Zheng","year":"2020","unstructured":"Zheng, M. et al. Bat SARS-Like WIV1 coronavirus uses the ACE2 of multiple animal species as receptor and evades IFITM3 restriction via TMPRSS2 activation of membrane fusion. Emerg. Microbes Infect. 9, 1567\u20131579 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"70095_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00519-25","volume":"99","author":"D Nguyen","year":"2025","unstructured":"Nguyen, D. et al. SARS-CoV-2 infection enhancement by amphotericin B: implications for disease management. J. Virol. 99, e0051925 (2025).","journal-title":"J. Virol."},{"key":"70095_CR21","doi-asserted-by":"publisher","unstructured":"Vir\u00e1g, E. et al. Repurposed nystatin to inhibit SARS-CoV-2 and mutants in the GI tract. bioRxiv, 2021.2010.2019.464931 https:\/\/doi.org\/10.1101\/2021.10.19.464931 (2021).","DOI":"10.1101\/2021.10.19.464931"},{"key":"70095_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2022.102467","volume":"77","author":"I Jim\u00e9nez-Mungu\u00eda","year":"2022","unstructured":"Jim\u00e9nez-Mungu\u00eda, I., Beaven, A. H., Blank, P. S., Sodt, A. J. & Zimmerberg, J. Interferon-induced transmembrane protein 3 (IFITM3) and its antiviral activity. Curr. Opin. Struct. Biol. 77, 102467 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"70095_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nsmb769","volume":"11","author":"MJ Rust","year":"2004","unstructured":"Rust, M. J., Lakadamyali, M., Zhang, F. & Zhuang, X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat. Struct. Mol. Biol. 11, 567\u2013573 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"70095_CR24","doi-asserted-by":"publisher","first-page":"e1001329","DOI":"10.1371\/journal.ppat.1001329","volume":"7","author":"E de Vries","year":"2011","unstructured":"de Vries, E. et al. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 7, e1001329 (2011).","journal-title":"PLoS Pathog."},{"key":"70095_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1146\/annurev-biochem-060208-104626","volume":"79","author":"J Mercer","year":"2010","unstructured":"Mercer, J., Schelhaas, M. & Helenius, A. Virus entry by endocytosis. Annu Rev. Biochem 79, 803\u2013833 (2010).","journal-title":"Annu Rev. Biochem"},{"key":"70095_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/tra.12389","volume":"17","author":"JM White","year":"2016","unstructured":"White, J. M. & Whittaker, G. R. Fusion of Enveloped Viruses in Endosomes. Traffic 17, 593\u2013614 (2016).","journal-title":"Traffic"},{"key":"70095_CR27","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1128\/JVI.80.4.2013-2018.2006","volume":"80","author":"T Sakai","year":"2006","unstructured":"Sakai, T. et al. Dual wavelength imaging allows analysis of membrane fusion of influenza virus inside cells. J. Virol. 80, 2013\u20132018 (2006).","journal-title":"J. Virol."},{"key":"70095_CR28","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.1128\/JVI.01254-16","volume":"90","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Constitutively expressed IFITM3 protein in human endothelial cells poses an early infection block to human influenza viruses. J. Virol. 90, 11157\u201311167 (2016).","journal-title":"J. Virol."},{"key":"70095_CR29","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.1128\/AAC.00612-12","volume":"56","author":"S Kagan","year":"2012","unstructured":"Kagan, S. et al. Toxicity mechanisms of amphotericin B and its neutralization by conjugation with arabinogalactan. Antimicrob. Agents Chemother. 56, 5603\u20135611 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70095_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3\u201320 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"70095_CR31","doi-asserted-by":"publisher","unstructured":"Yang, B. et al. SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome\/late endosome entry. Proc. Natl. Acad. Sci. USA 119 https:\/\/doi.org\/10.1073\/pnas.2117576119 (2022).","DOI":"10.1073\/pnas.2117576119"},{"key":"70095_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s44298-024-00080-y","volume":"2","author":"K Thankamani","year":"2024","unstructured":"Thankamani, K. et al. Middle East respiratory syndrome coronavirus (MERS-CoV) internalization does not rely on DPP4 cytoplasmic tail signaling. Npj Viruses 2, 67 (2024).","journal-title":"Npj Viruses"},{"key":"70095_CR33","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/AAC.38.10.2373","volume":"38","author":"A Vertut-Do\u00ef","year":"1994","unstructured":"Vertut-Do\u00ef, A., Ohnishi, S. I. & Bolard, J. The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B. Antimicrob. Agents Chemother. 38, 2373\u20132379 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"70095_CR34","doi-asserted-by":"publisher","unstructured":"Boer, D. E. C., van Smeden, J., Bouwstra, J. A. & Aerts, J. Glucocerebrosidase: functions in and beyond the lysosome. J. Clin. Med. 9 https:\/\/doi.org\/10.3390\/jcm9030736 (2020).","DOI":"10.3390\/jcm9030736"},{"key":"70095_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","volume":"90","author":"E Lauwers","year":"2016","unstructured":"Lauwers, E., Goodchild, R. & Verstreken, P. Membrane lipids in presynaptic function and disease. Neuron 90, 11\u201325 (2016).","journal-title":"Neuron"},{"key":"70095_CR36","doi-asserted-by":"publisher","unstructured":"Mulligan, R. J. & Winckler, B. Regulation of endosomal trafficking by Rab7 and its effectors in neurons: clues from Charcot-Marie-Tooth 2B Disease. Biomolecules 13 https:\/\/doi.org\/10.3390\/biom13091399 (2023).","DOI":"10.3390\/biom13091399"},{"key":"70095_CR37","doi-asserted-by":"publisher","unstructured":"Drews, K. et al. Glucosylceramidase maintains influenza virus infection by regulating endocytosis. J. Virol. 93 https:\/\/doi.org\/10.1128\/jvi.00017-19 (2019).","DOI":"10.1128\/jvi.00017-19"},{"key":"70095_CR38","doi-asserted-by":"publisher","first-page":"e0228735","DOI":"10.1371\/journal.pone.0228735","volume":"15","author":"K Drews","year":"2020","unstructured":"Drews, K. et al. Glucosylceramide synthase maintains influenza virus entry and infection. PLoS One 15, e0228735 (2020).","journal-title":"PLoS One"},{"key":"70095_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.antiviral.2005.11.002","volume":"69","author":"CM Finnegan","year":"2006","unstructured":"Finnegan, C. M. & Blumenthal, R. Fenretinide inhibits HIV infection by promoting viral endocytosis. Antivir. Res 69, 116\u2013123 (2006).","journal-title":"Antivir. Res"},{"key":"70095_CR40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fmicb.2020.00612","volume":"11","author":"A Audi","year":"2020","unstructured":"Audi, A., Soudani, N., Dbaibo, G. & Zaraket, H. Depletion of host and viral sphingomyelin impairs influenza virus infection. Front Microbiol 11, 612 (2020).","journal-title":"Front Microbiol"},{"key":"70095_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/22221751.2018.1559709","volume":"8","author":"S Schloer","year":"2019","unstructured":"Schloer, S. et al. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerg. Microbes Infect. 8, 80\u201393 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"70095_CR42","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1002\/jmv.26917","volume":"93","author":"E Van Damme","year":"2021","unstructured":"Van Damme, E. et al. In vitro activity of itraconazole against SARS-CoV-2. J. Med Virol. 93, 4454\u20134460 (2021).","journal-title":"J. Med Virol."},{"key":"70095_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41421-020-00217-2","volume":"6","author":"PG Wang","year":"2020","unstructured":"Wang, P. G., Tang, D. J., Hua, Z., Wang, Z. & An, J. Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation. Cell Discov. 6, 71 (2020).","journal-title":"Cell Discov."},{"key":"70095_CR44","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.3389\/fimmu.2018.01747","volume":"9","author":"I Celestino","year":"2018","unstructured":"Celestino, I. et al. Differential redox state contributes to sex disparities in the response to influenza virus infection in male and female mice. Front Immunol. 9, 1747 (2018).","journal-title":"Front Immunol."},{"key":"70095_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00974-21","volume":"12","author":"S Dhakal","year":"2021","unstructured":"Dhakal, S. et al. Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden syrian hamster model. mBio 12, e0097421 (2021).","journal-title":"mBio"},{"key":"70095_CR46","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/abbs\/gmaa179","volume":"53","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. NF-\u03baB and FosB mediate inflammation and oxidative stress in the blast lung injury of rats exposed to shock waves. Acta Biochim. Biophys. Sin. 53, 283\u2013293 (2021).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"70095_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103720","volume":"25","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. ACE2 can act as the secondary receptor in the Fc\u03b3R-dependent ADE of SARS-CoV-2 infection. iScience 25, 103720 (2022).","journal-title":"iScience"},{"key":"70095_CR48","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1083\/jcb.91.3.601","volume":"91","author":"KS Matlin","year":"1981","unstructured":"Matlin, K. S., Reggio, H., Helenius, A. & Simons, K. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91, 601\u2013613 (1981).","journal-title":"J. Cell Biol."},{"key":"70095_CR49","doi-asserted-by":"publisher","first-page":"e1011358","DOI":"10.1371\/journal.ppat.1011358","volume":"19","author":"N Kumar","year":"2023","unstructured":"Kumar, N. et al. Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo. PLoS Pathog. 19, e1011358 (2023).","journal-title":"PLoS Pathog."},{"key":"70095_CR50","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1257037","volume":"346","author":"I Banerjee","year":"2014","unstructured":"Banerjee, I. et al. Influenza A virus uses the aggresome processing machinery for host cell entry. Science 346, 473\u2013477 (2014).","journal-title":"Science"},{"key":"70095_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fcell.2017.00071","volume":"5","author":"L Ma","year":"2017","unstructured":"Ma, L., Ouyang, Q., Werthmann, G. C., Thompson, H. M. & Morrow, E. M. Live-cell Microscopy and Fluorescence-based Measurement of Luminal pH in Intracellular Organelles. Front Cell Dev. Biol. 5, 71 (2017).","journal-title":"Front Cell Dev. Biol."},{"key":"70095_CR52","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-60327-064-9_25","volume":"424","author":"ME de Ara\u00f9jo","year":"2008","unstructured":"de Ara\u00f9jo, M. E., Huber, L. A. & Stasyk, T. Isolation of endocitic organelles by density gradient centrifugation. Methods Mol. Biol. 424, 317\u2013331 (2008).","journal-title":"Methods Mol. Biol."},{"key":"70095_CR53","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cmet.2020.06.016","volume":"32","author":"JW Song","year":"2020","unstructured":"Song, J. W. et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32, 188\u2013202.e185 (2020).","journal-title":"Cell Metab."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70095-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70095-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:02:22Z","timestamp":1777179742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70095-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70095"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70095-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3670"}}